Stem cell, Haematopoiesis, Immunology, Progenitor cell and Molecular biology are his primary areas of study. The concepts of his Stem cell study are interwoven with issues in Bone marrow, Pathology and Adult stem cell. His study in Haematopoiesis is interdisciplinary in nature, drawing from both Interleukin, Erythropoietin and Tissue culture.
His study ties his expertise on Progenitor together with the subject of Immunology. His biological study spans a wide range of topics, including Cell culture, Cellular differentiation, Cell growth, Precursor cell and Granulocyte macrophage colony-stimulating factor. The study incorporates disciplines such as Interleukin 3, CD34, Epithelium and In situ hybridization in addition to Molecular biology.
His main research concerns Haematopoiesis, Stem cell, Immunology, Molecular biology and Progenitor cell. His Haematopoiesis research integrates issues from CD34, Cellular differentiation, Transplantation and Spleen. His research integrates issues of Endothelial stem cell, Adult stem cell and Bone marrow in his study of Stem cell.
His studies deal with areas such as Cell culture, Erythropoietin and Cell growth as well as Immunology. His research investigates the link between Molecular biology and topics such as Umbilical cord that cross with problems in Globin. His Progenitor cell research also works with subjects such as
Makio Ogawa mainly investigates Stem cell, Haematopoiesis, Bone marrow, Molecular biology and Hematopoietic stem cell. His Stem cell research is multidisciplinary, incorporating perspectives in Mesenchymal stem cell, Pathology, Immunology and Transplantation. The various areas that Makio Ogawa examines in his Immunology study include Natural killer cell and Interleukin 12.
His work carried out in the field of Haematopoiesis brings together such families of science as Progenitor cell, Cancer research and Cell type. His Bone marrow research is multidisciplinary, relying on both Stromal cell, Bone cell, CD34, Fibroblast and In vivo. Makio Ogawa usually deals with Molecular biology and limits it to topics linked to Cord blood and Pancreas, Nod and Cytotoxic T cell.
His main research concerns Stem cell, Bone marrow, Haematopoiesis, Hematopoietic stem cell and Cell biology. His primary area of study in Stem cell is in the field of Progenitor cell. His research in Bone marrow tackles topics such as In vivo which are related to areas like Type I collagen and Stromal cell.
His Haematopoiesis study combines topics in areas such as Cancer research, Immunology, CD34, Molecular biology and Transplantation. His work deals with themes such as Senescence, Cell aging and Downregulation and upregulation, which intersect with Immunology. His study looks at the intersection of Cell biology and topics like Cellular differentiation with Mesenchymal stem cell.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
AC133, a Novel Marker for Human Hematopoietic Stem and Progenitor Cells
Amy H. Yin;Sheri Miraglia;Esmail D. Zanjani;Graca Almeida-Porada.
Differentiation and Proliferation of Hematopoietic Stem Cells
Interleukin 6 enhancement of interleukin 3-dependent proliferation of multipotential hemopoietic progenitors.
Kenji Ikebuchi;Gordon G. Wong;Steven C. Clark;James N. Ihle.
Proceedings of the National Academy of Sciences of the United States of America (1987)
Reversible expression of CD34 by murine hematopoietic stem cells.
Takashi Sato;Joseph H. Laver;Makio Ogawa.
Human bone marrow CD34- cells engraft in vivo and undergo multilineage expression that includes giving rise to CD34+ cells.
Zanjani Ed;Almeida-Porada G;Livingston Ag;Flake Aw.
Experimental Hematology (1998)
Synergism between interleukin-6 and interleukin-3 in supporting proliferation of human hematopoietic stem cells: comparison with interleukin-1 alpha.
Anne G. Leary;Kenji Ikebuchi;Yoshikatsu Hirai;Gordon G. Wong.
Identification in culture of a class of hemopoietic colony-forming units with extensive capability to self-renew and generate multipotential hemopoietic colonies
Tatsutoshi Nakahata;Makio Ogawa.
Proceedings of the National Academy of Sciences of the United States of America (1982)
Hemorrhage, impaired hematopoiesis, and lethality in mouse embryos carrying a targeted disruption of the Fli1 transcription factor.
Demetri D. Spyropoulos;Pamela N. Pharr;Kim R. Lavenburg;Pascale Jackers.
Molecular and Cellular Biology (2000)
Thrombopoietin, the ligand for the Mpl receptor, synergizes with steel factor and other early acting cytokines in supporting proliferation of primitive hematopoietic progenitors of mice.
Hsun Ku;Yuji Yonemura;Kenneth Kaushansky;Makio Ogawa.
Granulocyte colony-stimulating factor enhances interleukin 3-dependent proliferation of multipotential hemopoietic progenitors.
Kenji Ikebuchi;Steven C. Clark;James N. Ihle;Lawrence M. Souza.
Proceedings of the National Academy of Sciences of the United States of America (1988)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: